My present research interest relates to the role of neuroactive inflammatory mediators in the pathogenesis of seizures and associated co-morbidities. Focus of the research is on preclinical characterization and development of novel anti-epileptogenic and disease-modifying treatments in animal models of epilepsy. My experience and qualification in this field is based on neuropharmacology, neurochemistry and immunohistochemistry background and on long-standing expertise with experimental epilepsy models with a focus on translational reserach.